The best of the plant. Despite the restriction on reimbursement, phytopharmaceuticals remain popular, and the need for advice and information in practices and pharmacies continues unabated. The experienced team of authors, consisting of doctors and pharmacists, evaluates 125 phytopharmaceuticals in 14 indication areas. They take into account current monographs from Commission E, ESCOP, and WHO, as well as S3 guidelines. The team provides concrete, evidence-based prescription recommendations, gives dosage and application instructions, names proven commercial preparations, describes tar formulations considering standard preparations, and identifies reimbursable phytopharmaceuticals.

New in this edition: complete revision and updating of all drug profiles, 26 additional drugs, phytopharmaceuticals for malignant tumor diseases, and hormonal and metabolic disorders. Safe advice, critical selection, effective treatment!.